• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • 14th Five-Year Plan for Drug Supervision Network Security and Information Construction in China

14th Five-Year Plan for Drug Supervision Network Security and Information Construction in China

14th Five-Year
Thursday, 26 May 2022 / Published in News, NMPA Registration in China, Pharmaceuticals & DMF

14th Five-Year Plan for Drug Supervision Network Security and Information Construction in China

The 14th Five-Year Plan for Drug Supervision Network Security and Information Construction in China issued (No.23-2022) by the NMPA on May 11, 2022, aims to:

  • Increase the capability for safety risk management on drug products
  • Optimize the strategic plan for intelligence supervision development on drugs
  • Modernize the drug regulatory framework with effective use of information technology
  • Promote the adaptation of innovative technology in the market surveillance of drugs

Review of the 13th Five-Year Plan

Since the release of the Action Plan of NMPA on Accelerating the Smart Regulation of Medicines, all Chinese drug regulatory departments have been actively supporting the development of smart market surveillance on drugs. As of today, the informatization of the basic infrastructure for drug surveillance is complete whilst national and provincial data centers, as well as regulatory boards are now competently available in China. These important developments set up a good foundation as the NMPA prepare to move forward to the 14th Five-Year Plan.

Objectives of the 14th Five-Year Plan

According to the 14th Five-Year Plan for Drug Supervision Network Security and Information Construction in China, the NMPA will focus on accomplishing the following 16 missions:

  • Upgrade the capabilities for:
    • smart surveillance on drug products
    • smart surveillance on medical device products
    • smart surveillance on cosmetic products
    • product traceability with an information-based system
    • monitoring adverse drug reactions with a complete national system
    • the supervision of professionals (inspectors, licensed pharmacist, etc.) under a unified system / platform
    • the use of mobile applications in the market surveillance of drugs, cosmetics, etc.
  • Upgrade the government capabilities by:
    • strengthening online services and administrative work enhancement
    • establishing a smart drug surveillance platform to be shared by the entire nation
  • Facilitate the use and integration of data resources for market surveillance
    • Refine the structure of national and provincial data centres
    • Improve the system for drug filing
    • Create a system for drug credibility and safety information
  • Strengthen the digital base for intelligent drug supervision
    • Refine the current system for the implementation / amendment of Chinese regulatory standards
    • Upgrade the NMPA cloud system
  • Improve cybersecurity, data security, and operating platforms
    • Refine the NMPA cybersecurity system
    • Refine the operating platforms for security management

By Yu and Jacky. If you would like to learn more about Measures for the Administration of Drug Registration or our registration and CRO services for pharmaceuticals, medical devices, IVDs, cosmetics, health foods, industrial or consumer goods contact Cisema.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers

What you can read next

Pilot Plan of the UDI System in Hainan Launched
Marketing Authorization Holder (MAH)
Supervision and administration of medical devices
Supervision and administration of medical device – sampling inspections finds 12 product failures

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...
  • China medical device quality safety responsibility

    China medical device quality and safety responsibility regulations come into force on March 1, 2023

    China medical device quality and safety respons...
  • China drug standards draft measures

    China drug standards draft measures have been published by the NMPA

    China drug standards draft measures have recent...
  • China special equipment safety supervision

    China special equipment safety supervision – draft provisions released

    China special equipment safety supervision regu...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.